Poseida Therapeutics Inc (PSTX)
2.73
+0.02
(+0.74%)
USD |
NASDAQ |
Nov 22, 16:00
2.86
+0.13
(+4.76%)
After-Hours: 20:00
Poseida Therapeutics Shareholders Equity (Quarterly): 87.21M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 87.21M |
| June 30, 2024 | 60.82M |
| March 31, 2024 | 84.59M |
| December 31, 2023 | 103.70M |
| September 30, 2023 | 123.66M |
| June 30, 2023 | 135.30M |
| March 31, 2023 | 157.56M |
| December 31, 2022 | 187.60M |
| September 30, 2022 | 216.31M |
| June 30, 2022 | 65.80M |
| Date | Value |
|---|---|
| March 31, 2022 | 103.70M |
| December 31, 2021 | 156.21M |
| September 30, 2021 | 150.16M |
| June 30, 2021 | 186.58M |
| March 31, 2021 | 227.49M |
| December 31, 2020 | 261.97M |
| September 30, 2020 | 295.84M |
| June 30, 2020 | -205.30M |
| March 31, 2020 | 47.04M |
| December 31, 2019 | -149.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-205.30M
Minimum
Jun 2020
295.84M
Maximum
Sep 2020
114.84M
Average
129.48M
Median
Shareholders Equity (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 278.55M |
| MaxCyte Inc | 213.30M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 293.58M |
| Total Liabilities (Quarterly) | 206.37M |
| Debt to Equity Ratio | 0.6755 |
| Current Ratio | 3.203 |
| Net Debt Paydown Yield | -0.04% |